Top Researchers
Top Medicine Researchers at University of Pittsburgh for 2026
The University of Pittsburgh has a strong presence in Medicine, with recent work spanning biomarker research, neurodegeneration, imaging, and population-level studies. Over the past year, researchers across the institution have been publishing in areas that connect laboratory measures, clinical decision-making, and broader questions in brain health.
Below, you’ll find a snapshot of the researchers whose recent output stood out most in this sample, along with the themes shaping their work. Together, these papers show how Pittsburgh-based teams are contributing to both specialized diagnostics and the wider understanding of disease.
Featured Researchers
Tharick A. Pascoal
Tharick A. Pascoal’s recent work at the University of Pittsburgh centers on Physiology, Psychiatry and Mental health, and Cognitive Neuroscience, with a strong emphasis on blood phosphorylated tau and healthy brain ageing.
Activity over the last year: 90 indexed journal articles.
Top publications:
- Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis (Aug 2025)
- Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease (Feb 2025)
- Social and health disparities associated with healthy brain ageing in Brazil and in other Latin American countries (Jan 2025)
Thomas K. Karikari
Thomas K. Karikari’s University of Pittsburgh publications focus on Physiology, Psychiatry and Mental health, and Neurology, particularly blood-based biomarkers and phospho-tau in Alzheimer’s disease.
Activity over the last year: 84 indexed journal articles.
Top publications:
- Alzheimer's Association Clinical Practice Guideline on the use of blood‐based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings (Jul 2025)
- Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis (Aug 2025)
- Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease (Feb 2025)
Guilherme Povala
Guilherme Povala’s recent output from the University of Pittsburgh spans Physiology, Psychiatry and Mental health, and Neurology, highlighting glial reactivity, neuroinflammation, and plasma GFAP.
Activity over the last year: 72 indexed journal articles.
Top publications:
- Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease (Jul 2025)
- Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration (Sep 2025)
- Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer's disease (May 2025)
Victor L. Villemagne
Victor L. Villemagne’s work at the University of Pittsburgh connects Psychiatry and Mental health, Physiology, and Radiology, Nuclear Medicine and Imaging through tau PET, plasma biomarkers, and amyloid-related studies.
Activity over the last year: 65 indexed journal articles.
Top publications:
- Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex (Jul 2025)
- Novel plasma biomarkers of amyloid plaque pathology and cortical thickness: Evaluation of the NULISA targeted proteomic platform in an ethnically diverse cohort (Feb 2025)
- Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration (Sep 2025)
Bruna Bellaver
Bruna Bellaver’s recent University of Pittsburgh research links Physiology, Psychiatry and Mental health, and Neurology, with papers on glial reactivity, neuroinflammation, and clinical trial enrichment in preclinical Alzheimer’s disease.
Activity over the last year: 68 indexed journal articles.
Top publications:
- Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease (Jul 2025)
- Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration (Sep 2025)
- Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer's disease (May 2025)
Ann D. Cohen
Ann D. Cohen’s University of Pittsburgh publications bring together Psychiatry and Mental health, Physiology, and Public Health, Environmental and Occupational Health, with attention to plasma biomarkers and cohort-based measurement studies.
Activity over the last year: 64 indexed journal articles.
Top publications:
- Novel plasma biomarkers of amyloid plaque pathology and cortical thickness: Evaluation of the NULISA targeted proteomic platform in an ethnically diverse cohort (Feb 2025)
- Equivalence of Plasma and Serum for Clinical Measurement of p‐tau217: Comparative Analyses of Four Blood‐Based Assays (Jul 2025)
- Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort (Jul 2025)
Firoza Z Lussier
Firoza Z Lussier’s recent work at the University of Pittsburgh spans Physiology, Psychiatry and Mental health, and Cognitive Neuroscience, focusing on glial reactivity, synaptic dysfunction, and neuroinflammation.
Activity over the last year: 69 indexed journal articles.
Top publications:
- Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease (Jul 2025)
- Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration (Sep 2025)
- Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer's disease (May 2025)
Jay Chhablani
Jay Chhablani’s University of Pittsburgh research is centered on Ophthalmology and Radiology, Nuclear Medicine and Imaging, with recent studies on pachychoroid disease, OCT angiography, and diabetic retinopathy.
Activity over the last year: 43 indexed journal articles.
Top publications:
- Pachychoroid disease spectrum: how multimodal imaging and OCT angiography have improved our knowledge (May 2025)
- Three-Dimensional Choroidal Vessels Assessment in Diabetic Retinopathy (Mar 2025)
- Clinical Characteristics and Progression of Pachychoroid Macular Atrophy in Central Serous Chorioretinopathy (Apr 2025)
What University of Pittsburgh's Medicine Community Is Working On
Across this sample, Physiology and Psychiatry and Mental health appear most often, showing a community deeply engaged with the biological underpinnings of brain disease and the clinical questions that follow. Neurology and Cognitive Neuroscience add a strong disease-mechanism and brain-function dimension, while Radiology, Nuclear Medicine and Imaging points to the importance of advanced measurement tools. Together, these subfields suggest an active research environment focused on biomarkers, neurodegeneration, and the ways imaging and cohort studies can improve diagnosis and understanding.- Physiology - seen across 7 of the featured researchers
- Psychiatry and Mental health - seen across 7 of the featured researchers
- Neurology - seen across 3 of the featured researchers
- Cognitive Neuroscience - seen across 2 of the featured researchers
- Radiology, Nuclear Medicine and Imaging - seen across 2 of the featured researchers
This collection offers a useful view of how Medicine at the University of Pittsburgh is evolving across related areas of investigation. If you’re exploring similar literature, it can be helpful to track authors, subfields, and recent publication patterns together. For researchers managing their own manuscripts, citation discovery, and submission preparation, Resub can help streamline the workflow.
Top researchers use tools to scale their productivity and impact. Try Livewrite for free today.